WAVE LIFE SCIENCES LTD. Impairment of Long-Lived Assets Held-for-use
WAVE LIFE SCIENCES LTD. (WVE) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-12-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2015-12-17
- 2015-09-30: Impairment of Long-Lived Assets Held-for-use 9 month $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 9 month |
|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |